Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Edgewise Therapeutics granted 74,000 inducement stock options to four new non-executive employees. The options were granted at an exercise price of $34.16, which matched the closing stock price on the grant date of May 29, 2026.
Key figures
- New employees
- 4
- Exercise price
- 34.16
- Shares granted
- 74000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.